𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs. Technology appraisal 225. June 2011.

Book ID
112180647
Publisher
Wiley (John Wiley & Sons)
Year
2011
Tongue
English
Weight
32 KB
Volume
22
Category
Article
ISSN
0959-6682

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Five-year followup of rheumatoid arthrit
Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year
✍ Suzan M. M. Verstappen; Johannes W. G. Jacobs; Johannes W. J. Bijlsma; Anton H. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate whether the clinical advantages observed after 1 year in a randomized controlled clinical trial, in which 2 treatment strategies were compared (the early disease‐modifying antirheumatic drug [DMARD] approach versus the pyramid approach), persist after 5 years.